Cognigenics
Eagle
About Cognigenics
Cognigenics transforms mental health in the genetic age through cognitive neuroengineering. The company’s business is cognitive neuroengineering, which is the genetic engineering of desirable cognitive traits, such as mindfulness, relaxation, and mental acuity. These cognitive assets can enhance human performance in normal individuals or offset cognitive deficits in people suffering from mental health issues such as stress, anxiety, and depression (which are the initial applications).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.6M
- Funding stage: Seed
- Last round: Seed (Aug 2022)
- Website: cognigenics.io
- Phone: 772-324-8800
Industries & Categories
Genetics, Mental Health, Neuroscience, Psychology
Social Profiles
Canonical: https://fsome.com/organization/cognigenics-70365 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.